The human immunodeficiency virus (HIV) continuum of care within the Inova Health System (IHS) has three levels of management: individual case management, linkage management, and disease-state management. Individual case management takes place at each operating unit— physician's office, hospital, home health care setting, or hospice—and has a multidisciplinary team that addresses treatment, education, therapy, and counseling. Inova Home Health and Hospice of Northern Virginia developed a staging tool to objectively determine the appropriate level of care and to provide a seamless transition between home health care and hospice. Inova's HIV Services provides the disease management component, incorporating proactive and cost-effective management of patients through the disease life cycle and across all settings.
Turjanica MA , Ardabell TR, Schiffer NA, Poirier M., Brodeur S.A multidisciplinary, multifaceted HIV program: Linking the resources. Nurs Admin Q.1994;18(2):41-45.
2.
Newell M.Using Nursing Case Management To Improve Health Outcomes. Gaithersburg, Md: Aspen; 1996.
3.
Dubois RW, Kosecoff J., Michelson LDDisease management: The maturation and application of health services research . Comp Ben Manage. Summer: 1995:20-29.
4.
Mauskopf J., Turner BJ, Markson LE, Houchens RL, Ganning TR, McKee L.Patterns of ambulatory care for AIDS patients and association with emergency room use. Health Serv Res.1994;29(4):489-510.
5.
Cotton DJ, ed. Optimism rises on combination therapy and protease inhibitor data. AIDS Clin Care.1996;8:1-23.
6.
Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med.1996; 334:701-706.
7.
Kaplan JE, Masur H., Holmes KK, Wilfert CM, et al. USPHS/ IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: An overview. Clin Infect Dis.1995;21 (suppl 1):S12-S31.
8.
Kaplan JE, Masur H., Holmes KK, McNeil MM, et al. USPHS/ IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Introduction. Clin Infect Dis.1995;21(suppl 1):S1-S11.
9.
Mor V., Laliberte L., Morris JN, Wiemann M.The Karnofsky performance scale: An examination of its reliability and validity in a research setting. Cancer.1984;53:2002-2007.
10.
Bruera E., Macmillan K., Hanson J., MacDonald RN. The Edmonton staging system for cancer pain: Preliminary report/ Cross Cancer Institute. University of Alberta, Edmonton, Canada. Pain. 1989;37(2):203-209.
11.
O'Brien WA, Hartigan PM, Martin D., Esinhart J., et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med.1996; 334:426-431.
